Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1955 1
1959 1
1960 1
1965 1
1966 1
1967 1
1969 1
1971 4
1972 2
1973 2
1974 7
1975 34
1976 14
1977 17
1978 16
1979 10
1980 13
1981 16
1982 26
1983 39
1984 76
1985 87
1986 116
1987 132
1988 108
1989 131
1990 147
1991 147
1992 186
1993 194
1994 196
1995 147
1996 37
1997 51
1998 36
1999 34
2000 30
2001 18
2002 38
2003 31
2004 29
2005 27
2006 43
2007 42
2008 51
2009 45
2010 50
2011 46
2012 51
2013 67
2014 67
2015 50
2016 46
2017 45
2018 51
2019 45
2020 64
2021 19
Text availability
Article attribute
Article type
Publication date

Search Results

2,850 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean sustain 250 (6,519 results)?
Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men.
Gharahdaghi N, Rudrappa S, Brook MS, Idris I, Crossland H, Hamrock C, Abdul Aziz MH, Kadi F, Tarum J, Greenhaff PL, Constantin-Teodosiu D, Cegielski J, Phillips BE, Wilkinson DJ, Szewczyk NJ, Smith K, Atherton PJ. Gharahdaghi N, et al. J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1276-1294. doi: 10.1002/jcsm.12472. Epub 2019 Sep 30. J Cachexia Sarcopenia Muscle. 2019. PMID: 31568675 Free PMC article. Clinical Trial.
BACKGROUND: The andropause is associated with declines in serum testosterone (T), loss of muscle mass (sarcopenia), and frailty. Two major interventions purported to offset sarcopenia are anabolic steroid therapies and resistance exercise training (RET). ...METHODS: Eighte …
BACKGROUND: The andropause is associated with declines in serum testosterone (T), loss of muscle mass (sarcopenia), and frailty. Two …
Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE, Yarrow JF. Borst SE, et al. Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1035-42. doi: 10.1152/ajpendo.00111.2015. Epub 2015 Apr 21. Am J Physiol Endocrinol Metab. 2015. PMID: 25898953 Free PMC article. Review.
The value of testosterone replacement therapy (TRT) for older men is currently a topic of intense debate. ...The normal range for serum testosterone is 300 to 1,000 ng/dl. Serum T 300 ng/dl is considered to be low, and T 250 is considered to be frank hypogona …
The value of testosterone replacement therapy (TRT) for older men is currently a topic of intense debate. ...The normal range for ser …
Testosterone Therapy and Prostate Cancer.
Davidson E, Morgentaler A. Davidson E, et al. Urol Clin North Am. 2016 May;43(2):209-16. doi: 10.1016/j.ucl.2016.01.007. Urol Clin North Am. 2016. PMID: 27132578 Review.
Changes in understanding regarding the relationship of androgens and prostate cancer have led to changes in the use of testosterone therapy. The evidence supports a finite ability of androgens to stimulate prostate cancer growth, with a maximum achieved at low testoster …
Changes in understanding regarding the relationship of androgens and prostate cancer have led to changes in the use of testosterone t …
Testosterone therapy and cardiovascular risk.
Walsh JP, Kitchens AC. Walsh JP, et al. Trends Cardiovasc Med. 2015 Apr;25(3):250-7. doi: 10.1016/j.tcm.2014.10.014. Epub 2014 Oct 28. Trends Cardiovasc Med. 2015. PMID: 25467243 Free article. Review.
Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. ...This review describes the findings and limitations of recent studies of cardiovascular risk in older men on testosterone therapy and …
Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. .. …
Testosterone, thrombophilia, thrombosis.
Glueck CJ, Friedman J, Hafeez A, Hassan A, Wang P. Glueck CJ, et al. Blood Coagul Fibrinolysis. 2014 Oct;25(7):683-7. doi: 10.1097/MBC.0000000000000126. Blood Coagul Fibrinolysis. 2014. PMID: 24732175
We assessed previously undiagnosed thrombophilia-hypofibrinolysis in 11 testosterone (T)-taking men, five of whom developed deep venous thrombosis (DVT), four pulmonary embolism, one spinal cord infarction, and one osteonecrosis 3.5 months (median) after starting T gel (50 …
We assessed previously undiagnosed thrombophilia-hypofibrinolysis in 11 testosterone (T)-taking men, five of whom developed deep veno …
"Prostate telocytes change their phenotype in response to castration or testosterone replacement".
Felisbino SL, Sanches BDA, Delella FK, Scarano WR, Dos Santos FCA, Vilamaior PSL, Taboga SR, Justulin LA. Felisbino SL, et al. Sci Rep. 2019 Mar 6;9(1):3761. doi: 10.1038/s41598-019-40465-1. Sci Rep. 2019. PMID: 30842587 Free PMC article.
The prostate is a complex gland capable of undergoing involution due to low testosterone levels; and this condition can be reversed with testosterone replacement. ...We called these cells "telocytes with a synthetic phenotype". As testosterone levels and glan …
The prostate is a complex gland capable of undergoing involution due to low testosterone levels; and this condition can be reversed w …
Androgens in the anaemia of chronic renal failure.
von Hartitzsch B, Kerr DN, Morley G, Marks B. von Hartitzsch B, et al. Nephron. 1977;18(1):13-20. doi: 10.1159/000180761. Nephron. 1977. PMID: 846623
Intramuscular testosterone (as Sustanon 250 once a week) elevated plasma TLS levels to above normal throughout the week with an initial high peak. ...A controlled trial of weekly Sustanon 250 in 24 regular dialysis patients produced a significan …
Intramuscular testosterone (as Sustanon 250 once a week) elevated plasma TLS levels to above normal throughout the week …
Reproduction in hens: is testosterone necessary for the ovulatory process?
Rangel PL, Gutierrez CG. Rangel PL, et al. Gen Comp Endocrinol. 2014 Jul 1;203:250-61. doi: 10.1016/j.ygcen.2014.03.040. Epub 2014 Apr 6. Gen Comp Endocrinol. 2014. PMID: 24717810 Review.
Progesterone (P4) is an inductor of the preovulatory surge of LH, while estradiol (E2) acts as a hypothalamic primer to allow P4 receptor development, as well as a stimulator of yolk production. Conversely, the role of testosterone (T) has been more controversial; however, …
Progesterone (P4) is an inductor of the preovulatory surge of LH, while estradiol (E2) acts as a hypothalamic primer to allow P4 receptor de …
2,850 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page